Immunomedics

$13.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-0.78%) As of 4:08 PM EDT pre-market
-$0.11 (-0.78%) Pre-Market

Why Robinhood?

You can buy or sell Immunomedics and other stocks, options, ETFs, and crypto commission-free!

About IMMU

Immunomedics, Inc. Common Stock, also called Immunomedics, is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. Read More It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Employees
346
Headquarters
Morris Plains, New Jersey
Founded
1982
Market Cap
2.67B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.70M
High Today
$14.24
Low Today
$13.84
Open Price
$14.05
Volume
1.78M
52 Week High
$26.99
52 Week Low
$11.55

Collections

IMMU News

ReutersAug 8

Edited Transcript of IMMU earnings conference call or presentation 7-Aug-19 9:00pm GMT

38

IMMU Earnings

-$0.68
-$0.46
-$0.24
-$0.02
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
Actual
Expected Nov 6, After Hours

Popular Stocks

More IMMU News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.